loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 21969 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CIPLA LIMITED (2)

filter

01 TABLET; ORAL (2)

filter

01 Blank (2)

filter

01 LAMIVUDINE; STAVUDINE; NEVIRAPINE (2)

filter

01 Blank (2)

URL Supplier Web Content
TABLET; ORAL
150MG; 40MG; 200MG
21969
LAMIVUDINE; STAVUD...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
150MG; 30MG; 200MG
21969
LAMIVUDINE; STAVUD...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 21969

Looking for FDA Orange Book APPLICATION 21969 2

19

Cipla, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is LAMIVUDINE; STAVUDINE; NEVIRAPINE, with a corresponding application number 21969.

With a dosage strength 150MG; 40MG; 200MG

Dosage Form Route TABLET; ORAL

18

Cipla, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is LAMIVUDINE; STAVUDINE; NEVIRAPINE, with a corresponding application number 21969.

With a dosage strength 150MG; 30MG; 200MG

Dosage Form Route TABLET; ORAL

Post Enquiry
POST ENQUIRY